Punt CJ - Search Results

1

WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy.

Bosch LJ, Luo Y, Lao VV, Snaebjornsson P, Trooskens G, Vlassenbroeck I, Mongera S, Tang W, Welcsh P, Herman JG, Koopman M, Nagtegaal ID, Punt CJ, van Criekinge W, Meijer GA, Monnat RJ Jr, Carvalho B, Grady WM. Bosch LJ, et al. Among authors: punt cj. Clin Cancer Res. 2016 Sep 15;22(18):4612-22. doi: 10.1158/1078-0432.CCR-15-2703. Epub 2016 Apr 27. Clin Cancer Res. 2016. PMID: 27121793 Free PMC article.

2

Alpha-interferon in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer: a phase I study.

Punt CJ, de Mulder PH, Burghouts JT, Wagener DJ. Punt CJ, et al. Cancer Chemother Pharmacol. 1992;29(4):326-8. doi: 10.1007/BF00685954. Cancer Chemother Pharmacol. 1992. PMID: 1537082 Clinical Trial.

3

Continuous infusion of high-dose 5-fluorouracil in combination with leucovorin and recombinant interferon-alpha-2b in patients with advanced colorectal cancer. A Multicenter Phase II study.

Punt CJ, Burghouts JT, Croles JJ, van Liessum PA, de Mulder PH, Kamm Y. Punt CJ, et al. Cancer. 1993 Oct 1;72(7):2107-11. doi: 10.1002/1097-0142(19931001)72:7<2107::aid-cncr2820720708>3.0.co;2-m. Cancer. 1993. PMID: 8374869 Clinical Trial.

4

Tallimustine in advanced previously untreated colorectal cancer, a phase II study.

Punt CJ, Humblet Y, Roca E, Dirix LY, Wainstein R, Polli A, Corradino I. Punt CJ, et al. Br J Cancer. 1996 Mar;73(6):803-4. doi: 10.1038/bjc.1996.140. Br J Cancer. 1996. PMID: 8611384 Free PMC article. Clinical Trial.

5

Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II study.

Punt CJ, van Herpen CM, Jansen RL, Vreugdenhil G, Muller EW, de Mulder PH. Punt CJ, et al. Br J Cancer. 1997;76(2):266-9. doi: 10.1038/bjc.1997.374. Br J Cancer. 1997. PMID: 9231931 Free PMC article. Clinical Trial.

6

Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancer.

Punt CJ, Voest EE, Tueni E, Van Oosterom AT, Backx A, De Mulder PH, Hecquet B, Lucas C, Gerard B, Bleiberg H. Punt CJ, et al. Br J Cancer. 1997;76(10):1376-81. doi: 10.1038/bjc.1997.563. Br J Cancer. 1997. PMID: 9374386 Free PMC article. Clinical Trial.

7

New drugs in the treatment of colorectal carcinoma.

Punt CJ. Punt CJ. Cancer. 1998 Aug 15;83(4):679-89. doi: 10.1002/(sici)1097-0142(19980815)83:4<679::aid-cncr8>3.0.co;2-f. Cancer. 1998. PMID: 9708931 Review.

8

Pharmacokinetics and bioavailability of oral 9-aminocamptothecin capsules in adult patients with solid tumors.

Sparreboom A, de Jonge MJ, Punt CJ, Nooter K, Loos WJ, Porro MG, Verweij J. Sparreboom A, et al. Among authors: punt cj. Clin Cancer Res. 1998 Aug;4(8):1915-9. Clin Cancer Res. 1998. PMID: 9717819 Clinical Trial.

9

Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients.

de Vries IJ, Lesterhuis WJ, Scharenborg NM, Engelen LP, Ruiter DJ, Gerritsen MJ, Croockewit S, Britten CM, Torensma R, Adema GJ, Figdor CG, Punt CJ. de Vries IJ, et al. Among authors: punt cj. Clin Cancer Res. 2003 Nov 1;9(14):5091-100. Clin Cancer Res. 2003. PMID: 14613986

10

Systemic treatment of advanced colorectal carcinoma.

van Laarhoven HW, Punt CJ. van Laarhoven HW, et al. Among authors: punt cj. Eur J Gastroenterol Hepatol. 2004 Mar;16(3):283-9. doi: 10.1097/00042737-200403000-00006. Eur J Gastroenterol Hepatol. 2004. PMID: 15195891 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

485 results

Search Page